abstract |
The invention relates to compounds of the formula I, to a process for their preparation and to their use as pharmaceuticals. ( I ) In particular, the compounds are used as inhibitors of prolyl-4-hydroxylase and as inhibitors of collagen biosynthesis, as pharmaceuticals against fibrotic diseases of the liver, the lung and the skin. |